174 related articles for article (PubMed ID: 26925647)
41. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
[TBL] [Abstract][Full Text] [Related]
42. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.
Luu TH; Bard JM; Carbonnelle D; Chaillou C; Huvelin JM; Bobin-Dubigeon C; Nazih H
Cell Oncol (Dordr); 2018 Feb; 41(1):13-24. PubMed ID: 28993998
[TBL] [Abstract][Full Text] [Related]
43. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of protein patterns of human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.
Flodrova D; Toporova L; Macejova D; Lastovickova M; Brtko J; Bobalova J
Gen Physiol Biophys; 2016 Jul; 35(3):387-92. PubMed ID: 27174898
[TBL] [Abstract][Full Text] [Related]
45. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.
Koutsilieris M; Reyes-Moreno C; Choki I; Sourla A; Doillon C; Pavlidis N
Mol Med; 1999 Feb; 5(2):86-97. PubMed ID: 10203574
[TBL] [Abstract][Full Text] [Related]
48. [Disparity of apoptotic response in human breast cancer cell lines MCF-7 and MDA-MB-231 after infection with recombinant adenovirus encoding the VP2 gene of infectious bursail disease virus].
Shin TS; Allaudin ZN; Lila MA; Rahman SO
Mol Biol (Mosk); 2014; 48(1):133-41. PubMed ID: 25842834
[TBL] [Abstract][Full Text] [Related]
49. Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells.
Phannasil P; Thuwajit C; Warnnissorn M; Wallace JC; MacDonald MJ; Jitrapakdee S
PLoS One; 2015; 10(6):e0129848. PubMed ID: 26070193
[TBL] [Abstract][Full Text] [Related]
50. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G
Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222
[TBL] [Abstract][Full Text] [Related]
51. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
52. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
[TBL] [Abstract][Full Text] [Related]
53. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
54. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
55. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells.
Kochetkova M; Kumar S; McColl SR
Cell Death Differ; 2009 May; 16(5):664-73. PubMed ID: 19136936
[TBL] [Abstract][Full Text] [Related]
56. Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis-resistant cancer cells.
Lee H; Park S; Kim JB; Kim J; Kim H
Cancer Lett; 2013 May; 332(1):110-9. PubMed ID: 23348696
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.
Karia P; Patel KV; Rathod SSP
J Ethnopharmacol; 2018 May; 217():54-62. PubMed ID: 29366766
[TBL] [Abstract][Full Text] [Related]
58. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
59. lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells.
Lu Q; Wang L; Gao Y; Zhu P; Li L; Wang X; Jin Y; Zhi X; Yu J; Li X; Qin X; Zhou P
Cancer Cell Int; 2021 Apr; 21(1):232. PubMed ID: 33902604
[TBL] [Abstract][Full Text] [Related]
60. Micro RNA-126 coordinates cell behavior and signaling cascades according to characteristics of breast cancer cells.
Turgut Cosan D; Oner C; Mutlu Sahin F
Bratisl Lek Listy; 2016; 117(11):639-647. PubMed ID: 28125889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
